{
    "clinical_study": {
        "@rank": "24924", 
        "acronym": "MINERVA", 
        "arm_group": [
            {
                "arm_group_label": "1", 
                "description": "Adults over 18 years old, with type 2 diabetes, HbA1c <= 8,5%, treated with oral antidiabetics at least for 6 months submitted to an educational programme during 1 year"
            }, 
            {
                "arm_group_label": "2", 
                "description": "Adults over 18 years old, with type 2 diabetes, HbA1c <= 8,5%, treated with oral antidiabetics at least for 6 months followed according to normal clinical practice during 1 year"
            }
        ], 
        "brief_summary": {
            "textblock": "Prospective study to evaluate the impact of an educational programme about diabetes,\n      comparing to normal clinical practice, on treatment compliance and disease control of people\n      with type 2 diabetes followed in the primary care units in Portugal."
        }, 
        "brief_title": "Better Diabetes Control, Quality - Educate to Achieve Compliance", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetes Type 2", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Individuals with type 2 diabetes\n\n          -  HbA1c <= 8,5%\n\n          -  Treated with oral antidiabetics for at least 6 months\n\n        Exclusion Criteria:\n\n        - Treatment with insulin"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "primary care setting patients"
            }
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01728714", 
            "org_study_id": "NIS-CPO-XXX-2012/1"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Diabetes; compliance", 
        "lastchanged_date": "April 30, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Espinho", 
                        "country": "Portugal"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Loures", 
                        "country": "Portugal"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Santo Antonio dos Cavaleiros", 
                        "country": "Portugal"
                    }, 
                    "name": "Research Site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Portugal"
        }, 
        "number_of_groups": "2", 
        "official_title": "Prospective Study to Evaluate the Impact of an Educational Programme About Diabetes, Comparing to Normal Clinical Practice, on Treatment Compliance and Disease Control of People With Type 2 Diabetes Followed in the Primary Care Units in Portugal.", 
        "overall_contact": {
            "email": "sandra.barbosa@astrazeneca.com", 
            "last_name": "AstraZeneca Portugal Clinical Study Information", 
            "phone": "00351214345720"
        }, 
        "overall_contact_backup": {
            "email": "anarita.lima@astrazeneca.com", 
            "last_name": "Ana Rita Lima"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Portugal: National Data Protection Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of people with type 2 diabetes treated with oral antidiabetics assessed as compliant with treatment after 1 year educational programme on diabetes, compared with normal clinical practice.", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01728714"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Number of people with type 2 diabetes treated with oral antidiabetics assessed as compliant with diet and physical exercise after 1 year educational programme on diabetes, compared with normal clinical practice.", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Number of people with type 2 diabetes treated with oral antidiabetics assessed as compliant with treatment with oral antidiabetics;after 1 year educational programme on diabetes, compared with normal clinical practice.", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Measure impact on quality of life, perceived by the patient, following 1 year educational programme on diabetes, compared with normal clinical practice.", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Measure the impact of compliance with treatment on glucose control following 1 year educational programme on diabetes, compared with normal clinical practice.", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Measure level of satisfaction of the patient with treatment and medical care following 1 year educational programme on diabetes, compared with normal clinical practice.", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "AstraZeneca", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "AstraZeneca", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}